We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid POC Salivary Diagnostic Technology Shows Potential for Detecting Various Disease Biomarkers

By HospiMedica International staff writers
Posted on 15 May 2023

Across the globe, approximately 3. More...

5 billion individuals are currently afflicted by oral diseases. Numerous oral bacteria are also associated with systemic illnesses such as diabetes, heart disease, and cancer. Now, a new diagnostic tool that can be used in a dental office analyzes saliva samples to provide comprehensive information on oral health and determine the risk for cavities and gum disease and systemic diseases.

Scientists from the Forsyth Institute (Cambridge, MA, USA) have demonstrated a CRISPR-based technology that can identify specific oral pathogens in approximately half an hour. The SHERLOCK system, a CRISPR-Cas molecular diagnostic platform, can accurately pinpoint and target RNA and DNA molecules in a sequence-specific manner. This technology has been tailored to target four oral bacteria known to contribute to oral health issues, such as periodontitis (gum disease) and dental cavities. The new point-of-care diagnostic technology could revolutionize dental care and facilitate early disease detection, eliminating the discomfort, inconvenience, and expense of blood tests.

In the recent study, the researchers tested the system on three bacteria associated with a variety of conditions, including cancer, digestive diseases, cardiovascular diseases, and neurodegenerative diseases. The findings indicated the impressive adaptability of the diagnostic tool to identify any biomarker from saliva, including markers related to inflammation and cancer. Using this innovative detection method, a person could simply provide a saliva sample and receive highly precise results in a minimal amount of time. This test could be administered in a dental clinic without the need for specialized skills.

“Targeted treatments are only possible when you know which bugs are in the mouth. In any disease, we cannot begin to create effective treatments until we have diagnostics,” said Dr. Batbileg Bor, who led the study and is an Assistant Member of Staff at Forsyth. “Currently, available tests on the market are either low sensitivity or require analysis at an expensive centralized laboratory. It can take months to get the results. The studied detection tool solves both problems, featuring high-sensitivity, low-cost tests with rapid results.”

“The test is so sensitive it can detect as little as 10s of bacteria cells of a certain type from a sample that might contain around 200 species of bacteria commonly found in your mouth,” added Dr. Bor. “We were able to target and detect specific bacteria in unprocessed saliva, meaning we could get this level of sensitivity and specificity without having to additionally process the saliva sample.”

Related Links:
Forsyth Institute 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Patient Preoperative Skin Preparation
BD ChloraPrep
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The proposed sensor incorporates two ion-selective electrodes and a liquid-junction reference electrode, which allows the device to operate without the need for long pre-adjustment periods. (Photo courtesy of Associate Professor Isao Shitanda from Tokyo University of Science, Japan)

Wristwatch Sensor Tracks Sodium and Potassium in Sweat in Real Time

Sweat can provide real-time biochemical information about the body’s physiological state, with sodium and potassium measurements offering potential value for monitoring people working or exercising in... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.